Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL

被引:60
|
作者
Muino, Elena [1 ]
Gallego-Fabrega, Cristina [1 ]
Cullell, Natalia [1 ]
Carrera, Caty [2 ]
Torres, Nuria [1 ]
Krupinski, Jurek [3 ]
Roquer, Jaume [4 ]
Montaner, Joan [2 ]
Fernandez-Cadenas, Israel [1 ]
机构
[1] Hosp Mutua Terrassa, Fundacio Docencia & Recerca Mutua Terrassa, Stroke Pharmacogen & Genet, Terrassa 08221, Spain
[2] Hosp Valle De Hebron, Neurovasc Res Lab, Vall dHebron Inst Res, Barcelona 08035, Spain
[3] Hosp Mutua Terrassa, Neurol Serv, Terrassa 08221, Spain
[4] Hosp Mar, IMIM, Inst Hosp Mar Invest Med, Neurol Serv, Barcelona 08003, Spain
来源
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2017年 / 18卷 / 09期
关键词
CADASIL; cysteine; NOTCH3; mutation; temporal pole; AUTOSOMAL-DOMINANT ARTERIOPATHY; SUBCORTICAL INFARCTS; LEUKOENCEPHALOPATHY CADASIL; GENE; PATHOGENESIS; DIAGNOSIS; FAMILIES; RESIDUE; JAPAN; POLYMORPHISM;
D O I
10.3390/ijms18091964
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is caused by mutations in the NOTCH3 gene, affecting the number of cysteines in the extracellular domain of the receptor, causing protein misfolding and receptor aggregation. The pathogenic role of cysteine-sparing NOTCH3 missense mutations in patients with typical clinical CADASIL syndrome is unknown. The aim of this article is to describe these mutations to clarify if any could be potentially pathogenic. Articles on cysteine-sparing NOTCH3 missense mutations in patients with clinical suspicion of CADASIL were reviewed. Mutations were considered potentially pathogenic if patients had: (a) typical clinical CADASIL syndrome; (b) diffuse white matter hyperintensities; (c) the 33 NOTCH3 exons analyzed; (d) mutations that were not polymorphisms; and (e) Granular osmiophilic material (GOM) deposits in the skin biopsy. Twenty-five different mutations were listed. Four fulfill the above criteria: p.R61W; p.R75P; p.D80G; and p.R213K. Patients carrying these mutations had typical clinical CADASIL syndrome and diffuse white matter hyperintensities, mostly without anterior temporal pole involvement. Cysteine-sparing NOTCH3 missense mutations are associated with typical clinical CADASIL syndrome and typical magnetic resonance imaging (MRI) findings, although with less involvement of the anterior temporal lobe. Hence, these mutations should be further studied to confirm their pathological role in CADASIL.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant
    Bersano, Anna
    Ranieri, Michela
    Ciammola, Andrea
    Cinnante, Claudia
    Lanfranconi, Silvia
    Dotti, Maria Teresa
    Candelise, Livia
    Baschirotto, Cinzia
    Ghione, Isabella
    Ballabio, Elena
    Bresolin, Nereo
    Bassi, Maria Teresa
    FUNCTIONAL NEUROLOGY, 2012, 27 (04) : 247 - 252
  • [32] NOTCH3 mutations in a cohort of Portuguese patients within CADASIL spectrum phenotype
    Maria Rosário Almeida
    Inês Elias
    Carolina Fernandes
    Rita Machado
    Orlando Galego
    Gustavo Santo
    neurogenetics, 2022, 23 : 1 - 9
  • [33] NOTCH3 gene mutations in subjects clinically suspected of CADASIL
    Mosca, Lorena
    Marazzi, Raffaella
    Ciccone, Alfonso
    Santilli, Ignazio
    Bersano, Anna
    Sansone, Valeria
    Grosso, Enrico
    Mandrile, Giorgia
    Giachino, Daniela Francesca
    Adobbati, Laura
    Corengia, Elisabetta
    Agostoni, Elio
    Fiumani, Anna
    Gallone, Salvatore
    Scarpini, Elio
    Guidotti, Mario
    Sterzi, Roberto
    Ajmone, Clara
    Marocchi, Alessandro
    Penco, Silvana
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 307 (1-2) : 144 - 148
  • [34] Novel dot-blot assay for detection of vascular Notch3 aggregates in patients with CADASIL
    Ma, Yihong
    Ueda, Mitsuharu
    Ueda, Akihiko
    Shinriki, Satoru
    Nagatoshi, Akihito
    Isoguchi, Aito
    Okada, Masamitsu
    Tasaki, Masayoshi
    Nomura, Toshiya
    Inoue, Yasuteru
    Masuda, Teruaki
    Misumi, Yohei
    Yamashita, Taro
    Matsui, Hirotaka
    Ando, Yukio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 415
  • [35] A CADASIL case with normal skin biopsy and without mutations in exons 3 and 4 of the Notch3 gene
    de Freitas, GR
    Miklossy, J
    Christen-Zäch, S
    Reichhart, M
    Bogousslavsky, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 193 (01) : 43 - 47
  • [36] Genetic diagnosis of CADASIL in three Hong Kong Chinese patients: A novel mutation within the intracellular domain of NOTCH3
    Hung, Ling Yin
    Ling, Tsz Ki
    Lau, Nike Kwai Cheung
    Cheung, Wing Lan
    Chong, Yeow Kuan
    Sheng, Bun
    Kwok, King Ming
    Mak, Chloe Miu
    JOURNAL OF CLINICAL NEUROSCIENCE, 2018, 56 : 95 - +
  • [37] Effect of NOTCH3 EGFr Group, Sex, and Cardiovascular Risk Factors on CADASIL Clinical and Neuroimaging Outcomes
    Hack, Remco J.
    Cerfontaine, Minne N.
    Gravesteijn, Gido
    Tap, Stephan
    Hafkemeijer, Anne
    van der Grond, Jeroen
    Witjes-Ane, Marie-Noelle
    Baas, Frank
    Rutten, Julie W.
    Oberstein, Saskia A. J. Lesnik
    STROKE, 2022, 53 (10) : 3133 - 3144
  • [38] Mutations of the Notch3 gene in non-caucasian patients with suspected CADASIL syndrome
    Kotorii, S
    Takahashi, K
    Kamimura, K
    Nishio, T
    Arima, K
    Yamada, H
    Uyama, E
    Uchino, M
    Suenaga, A
    Matsumoto, M
    Kuchel, G
    Rouleau, GA
    Tabira, T
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (03) : 185 - 193
  • [39] Genetic spectrum of NOTCH3 and clinical phenotype of CADASIL patients in different populations
    Ni, Wang
    Zhang, Yi
    Zhang, Liang
    Xie, Juan-Juan
    Li, Hong-Fu
    Wu, Zhi-Ying
    CNS NEUROSCIENCE & THERAPEUTICS, 2022, 28 (11) : 1779 - 1789
  • [40] Progress to Clarify How NOTCH3 Mutations Lead to CADASIL, a Hereditary Cerebral Small Vessel Disease
    Mizuta, Ikuko
    Nakao-Azuma, Yumiko
    Yoshida, Hideki
    Yamaguchi, Masamitsu
    Mizuno, Toshiki
    BIOMOLECULES, 2024, 14 (01)